Abstract |
Type 2 diabetes mellitus is associated with a poor quality of life and considerable health-care costs and can be difficult to control. The recent results from the HARMONY 3 and HARMONY 6 trials suggest that albiglutide is a safe and effective treatment option for patients with type 2 diabetes mellitus.
|
Authors | Giuseppe Derosa, Pamela Maffioli |
Journal | Nature reviews. Endocrinology
(Nat Rev Endocrinol)
Vol. 10
Issue 9
Pg. 514-6
(Sep 2014)
ISSN: 1759-5037 [Electronic] England |
PMID | 25069463
(Publication Type: Journal Article, Comment)
|
Chemical References |
- Hypoglycemic Agents
- Pyrazines
- Sulfonylurea Compounds
- Triazoles
- Glucagon-Like Peptide 1
|
Topics |
- Diabetes Mellitus, Type 2
(drug therapy)
- Female
- Glucagon-Like Peptide 1
(analogs & derivatives)
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Male
- Pyrazines
(therapeutic use)
- Sulfonylurea Compounds
(therapeutic use)
- Triazoles
(therapeutic use)
|